Unstable startup waiting to get bought out - Anonymous employee Proscia Employee Review

1.0
Oct 13, 2023
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

“Unlimited PTO” - although you are expected to work OT and vacation approval is conditional

Cons

Working with people who has no awareness of the market or space they are in….majority of the people are washed out from other major competitors that’s been around for a while. Company’s strategy can be questionable in some areas and you are not allowed to challenge some decisions from the top. Products are build and optimized to please few biggest customers instead of taking a look at solving market problems. The product lead mentioned multiple times on how “we don’t look at what or how the competition is doing”… lol yes because the competition has significantly better products and actually listen to what people need instead of a few people internally “who think this is how a product should work so let’s march towards that”.

Explore other reviews about Proscia

5.0
Dec 16, 2025
Recommend
CEO approval
Business Outlook

Pros

Great company with a great mission. The company is honest and fueled by brilliant individuals who all share the same end goal. This makes innovating on the daily super easy

Cons

Nothing to share for cons

2.0
Feb 4, 2026
Recommend
CEO approval
Business Outlook

Pros

-Mission-driven company working on meaningful problems in digital pathology and precision medicine -Smart, passionate people who genuinely care about advancing the field -Strong product vision with real long-term potential -Opportunity to take ownership and operate independently -Fast learning curve if you’re comfortable figuring things out as you go

Cons

-Early-stage startup realities are not always clearly communicated, especially around sales timelines and expectations -Sales roles face long, complex cycles in regulated environments, which can conflict with short-term quota pressure -Limited enablement and structure for go-to-market execution, particularly for newer or emerging markets -Leadership team has deep technical expertise but limited firsthand experience selling into highly regulated clinical and life sciences settings -Rapid shifts in strategy can make prioritization and execution challenging

See reviews by: Helpful|Rating|Date|All